Do not forget this is an interim review at half wa
Post# of 148169
Quote:That is correct, and given a previous presented hypothesis that maybe not enough placebo subjects died, you have to ask yourself how many of the remaining 8-9 placebo subjects will die?
Do not forget this is an interim review at half way. They could say "looks good so far call when you finish the full 390".
26 Subjects Remaining to 195
26 / 3 = 8.66 Placebo Subjects
However, I will mention that I found it interesting that the DSMC looked at 149 subjects -- because we only had 120 subjects enrolled on July 3.
That was only 31 days ago, and the Day 28 PE is 28 days.
Maybe they looked at more subjects on the basis of the Day 14 secondary endpoint.